评估GPT-4在回答关于疼痛治疗的临床药理学问题的准确性
Anna Stroop1, Tabea Stroop2, Samer Zawy Alsofy1,3
1Faculty of Health, Department of Medicine, Witten-Herdecke University, Witten, Germany.
British journal of clinical pharmacology
|March 11, 2025
概括
GPT-4在提供患者疼痛管理信息方面表现有前途,在准确性和可理解性方面得分高. 然而,它需要进一步开发完整的药理数据,以确保可靠性.
科学领域:
- 人工智能在医学中的应用
- 临床药理学 临床药理学
- 疼痛管理疗法治疗方法
背景情况:
- 像GPT-4这样的大型语言模型 (LLM) 越来越多地被用于医疗信息传递.
- 评估LLM产生的医学内容的准确性和完整性对于患者安全和临床决策至关重要.
- 疼痛治疗涉及复杂的药理学考虑,包括药物相互作用,剂量和禁忌.
研究的目的:
- 评估GPT-4在回答有关疼痛管理的临床药理学问题的准确性和完整性.
- 评估GPT-4的可靠性,作为疼痛治疗中面向患者的医疗信息的来源.
- 确定GPT-4是否适用于治疗疼痛的临床决策支持.
主要方法:
- 一项横截面调查涉及医疗保健专业人员 (医生,药剂师) 提交疼痛管理药理学问题.
- 分析了GPT-4反应的可理解性,细节性,满意度,医药学准确性和完整性.
- 响应的准确性与德国药物目录交叉引用.
主要成果:
- 参与者对GPT-4的反应高度可理解 (99%),并被认为是医学上准确的 (96%).
- 报告总体满意度高 (93%) 和详细信息 (84%),但完整性较低 (63%).
- 在药理动力学和药物相互作用数据中发现了差距;系统可用性量表得分为83.38.8.
结论:
- GPT-4显示了在疼痛管理中提供医疗信息的潜力,但由于数据不完整,需要精细化.
- 局限性包括药理学数据的潜在缺口和对话性AI中的上下文转载问题.
- 建议开发与实时数据库集成的专门AI工具,以提高临床可靠性.
相关概念视频
Analgesia and Pain Management
392
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
392
Drug Administration and Therapy Phases: Overview
370
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
370
Clinical Trials: Overview
2.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
167
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
167
Preclinical Development: Overview
4.0K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.0K


